N-isovaleryl-L-alanine

Metabolite details

Identifier

OJPSNARFDYTAEN-LURJTMIESA-N

InChI Key

OJPSNARFDYTAEN-LURJTMIESA-N

IUPAC name

N-(3-methylbutanoyl)-L-alanine

Preferred name

N-isovaleryl-L-alanine

INN name

—

Synonym

(2S)-2-(3-methylbutanamido)propanoic acid

ChEBI

CHEBI:136818

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Wild_type_vs_hfq
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G1_PBS_vs_G2_DSS
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d